The Effects of PegIntron Plus Rebetol in Subjects With Chronic Hepatitis C Not Responding to Pegasys (Study P03833)

NCT00441584 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

117

Enrollment

INDUSTRY

Sponsor class

Stopped Subject accrual was prematurely terminated due slow enrollment.

Conditions

Hepatitis C, Chronic

Interventions

BIOLOGICAL: PegIntron (peginterferon alfa-2b)
DRUG: Rebetol (ribavirin)

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]